Home . Resources
[Webinar] How to better optimize an oncology drug discovery program
Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.
Read more Read the full press release about our very good results in 2021 & an attractive outlook for 2022 for the group & our BUs Service, Biotech & AI.
Read all the details of the collaboration agreement for R&D of a new personalized cancer treatment for aggressive and untreatable tumors.
Find all the 2021 financial information: 2021 turnover of €31.3M, up by 22%, and expects to break even and dive into the BU financial results
Oncodesign announces all the regulatory dates as far as financial information is concerned. Let's have a look :)
Oncodesign adds a new high-level competence to its COMEX to achieve its external growth objectives with Karine Lignel.
Read all the financial information of Oncodesign and its Business Units Service, Biotech and Artificial Intelligence.
Group turnover up by 33% at €15.8M. Despite the global health crisis, which continues to limit international travel...
Oncodesign strenghens its Board by appointing Aline Aubertin as new independent director.
[Press Release] Explore our brand new service offer DRIVE-MRT. it allows the rationalization, design and optimization of targeted radiopharmaceutical products that are effective against certain metastatic cancers.
[Press Release] Find the update of the RIPK2 program and the start of new programs associated with Nanocyclix.
[Press Release] Oncodesign maintains its revenue and operating income at €38 million in 2020 and is anticipating an operating profit for the 2nd straight year, within the context of the global public health crisis
Read PRess Release to have an insight on how to organize & leverage healthcare data to accelerate the search for new treatments in oncology using AI.